Repligen (RGEN) Invested Capital (2010 - 2026)

Repligen (RGEN) has 17 years of Invested Capital data on file, last reported at $2.7 billion in Q1 2026.

• Invested Capital for Q1 2026 came in at $2.7 billion, up 31.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (up 31.33% YoY), and the FY2025 annual result was $2.6 billion, up 6.01% from the prior year.
• Invested Capital steadied at $2.7 billion in Q1 2026 per RGEN's latest filing, from $2.6 billion in the prior quarter.
• Over five years, Invested Capital peaked at $2.7 billion in Q1 2026 and troughed at $1.8 billion in Q1 2022.
• A 5-year average of $2.2 billion and a median of $2.1 billion in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2023 and 2025: Invested Capital soared 33.26% in 2023, then declined 21.29% in 2025.
• A 5-year view of Invested Capital shows it stood at $1.9 billion in 2022, then surged by 33.26% to $2.6 billion in 2023, then retreated by 2.6% to $2.5 billion in 2024, then rose by 6.01% to $2.6 billion in 2025, then grew by 0.14% to $2.7 billion in 2026.
• Business Quant data shows RGEN's Invested Capital at $2.7 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.